The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

The European Commission has established the European Health and Digital Executive Agency (HaDEA)

On 1 April, the European Commission has newly established the European Health and Digital Executive...

find out more ›

President Biden’s plans to establish HARPA

U.S. President Joe Biden is considering plans to create an Advanced Research Projects Agency for Health (HARPA). This entity would support the funding of...

find out more ›

Avicenna provides input to the European Parliament Special Committee on Beating Cancer

Early March, the Avicenna Alliance had the opportunity to provide the European Parliament’s Committee on...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up